The Buck Institute for Research on Aging today announced the launch of Healthspan Horizons, a new initiative designed to address one of the most urgent challenges in modern medicine: how to measure, understand, and extend healthspan-the years of life spent in good health.

6 Mar 2026

Redefining end-of-life care for better patient outcomes

Specialist palliative care has the potential to reduce costs by up to £8,000 per person and improve quality of life.

6 Mar 2026

Trial aims to improve family communication about inherited colorectal cancer risk

In time for Colorectal Cancer Awareness Month in March, the Alliance for Clinical Trials in Oncology has launched a new clinical study aimed at helping improve how patients with colorectal cancer share information about the genetic risks to their family members.

5 Mar 2026

Menstrual stigma influences work, school and social participation

Only 1 in 6 participants maintain their daily activities without change during menstruation, according to a study on menstrual health conducted in Spain and led by the INGENIO Institute (UPV-CSIC).

5 Mar 2026

Study identifies the hidden challenges of women with gestational diabetes

A study from University of Limerick in Ireland has identified the hidden challenges of women living with and managing Gestational Diabetes Mellitus (GDM).

5 Mar 2026

Repurposed kidney drug finerenone shows promise in treating premature ovarian insufficiency

Premature ovarian insufficiency (POI) is a clinically significant cause of infertility that affects between 1 to 3% of women of childbearing age.

5 Mar 2026

Spatial intelligence platform supports health policy decisions aimed at ending HIV

INCLIVA Healthcare Research Institute-University Clinical Hospital of Valencia, the Universitat Politècnica de València - through its VRAIN Institute, the Valencia Anti-AIDS Committee and the Centre for Epidemiological Studies on Sexually Transmitted Infections and AIDS in Catalonia (CEEISCAT) have joined forces to develop a spatial intelligence platform to support health policy decisions aimed at optimizing the prevention of human immunodeficiency virus (HIV) and accelerating its early diagnosis.

5 Mar 2026

Detecting major neurological disorders via saliva

A team of Korean researchers has, for the first time in the world, developed a technology capable of enabling early diagnosis of major neurological disorders, including epilepsy, Parkinson's disease, and schizophrenia, using only a small amount of saliva.

5 Mar 2026

Tailoring digital safety to the child’s developmental stage

The use of generative artificial intelligence (AI), able to produce text, images and video on demand, has grown exponentially in recent years. While its applications for personal and professional use continue to expand, many have questions about how children might be interacting with this technology.

5 Mar 2026

Environmental swabs reveal hidden avian viral diversity

Scientists at Duke-NUS Medical School have found that viruses circulating in live poultry markets can be detected more effectively by sampling the surrounding environment than by testing individual birds. The study, published in Nature Communications, shows that environmental sampling can uncover a broader range of poultry viruses-including highly pathogenic avian influenza strains that traditional surveillance may miss.

5 Mar 2026

GLP-1 drugs may be effective at treating and preventing substance use disorders

Researchers at Washington University School of Medicine in St. Louis show in a new study that GLP-1 medications may be effective at treating and preventing substance use disorders across all major addictive substances studied, suggesting these drugs target a common biological pathway underlying addiction.

4 Mar 2026

Georgia Tech receives major funding to develop lymphatic disease therapy

The Georgia Institute of Technology has been awarded up to $21.8 million from the Advanced Research Projects Agency for Health (ARPA-H) to deliver a first-of-its-kind therapy to patients with lymphatic disease.

4 Mar 2026

Why measles remains one of the most contagious viral diseases worldwide

This review synthesizes current evidence on measles virus biology, immune responses, complications, treatments, and prevention strategies. It highlights how measles can suppress immune memory, increasing susceptibility to other infections, and underscores vaccination as the most effective control measure.

4 Mar 2026

Newer nurses face the highest risk of developing moral injury symptoms

Moral injury remains prevalent among critical care nurses, with newer nurses at the highest risk of developing symptoms, according to new research published in American Journal of Critical Care.

4 Mar 2026

Periodontal bacteria trigger bone density reduction via the gut

Periodontitis, a chronic inflammatory disease of the gums, affects hundreds of millions of people worldwide and is increasingly linked to systemic disorders beyond the oral cavity.

4 Mar 2026

Removing patient fees doubles digital healthcare consultations among young adults

Young adults are more likely to consume healthcare when it is available via healthcare apps, and even more so if they do not have to pay patient fees.

4 Mar 2026

Vaginal estrogen therapy is safe for young endometrial cancer survivors, study finds

Despite the increased incidence of endometrial cancer in younger women, there is limited research regarding the safety of local, low-dose vaginal estrogen therapy (ET) for survivors.

4 Mar 2026

Childhood cavities and gum disease raise adult heart disease risk

The link between childhood oral health and adult heart disease underscores the need for preventive dental care to enhance lifelong cardiovascular health.

4 Mar 2026

Lawmakers, health groups resist their states’ rural health fund plans

In the final days of 2025, governors around the country trumpeted the hundreds of millions of federal dollars they won from a new, $50 billion rural health fund.

4 Mar 2026

Mursla Bio accelerates US commercial deployment of EvoLiver through ABHI program

Mursla Bio, a leader in Extracellular Vesicle (EV) science on a mission to significantly improve chronic disease outcomes for at-risk patients, today announced it has been selected to join the Association of British HealthTech Industries (ABHI) US Accelerator.

4 Mar 2026